Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 13/20 | 0.35 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.33 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.32 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15137866 | 0.92 | IDH1 (0.38) | IDH1AGTR2 | |
| SCHEMBL10185908 | 0.90 | IDH1 (0.35) | IDH1AGTR2BDKRB1 | |
| SCHEMBL10184022 | 0.88 | IDH1 (0.30) | IDH1NPC1 | |
| SCHEMBL10183311 | 0.83 | IDH1 (0.34) | IDH1AGTR2NPC1 | |
| SCHEMBL10183312 | 0.83 | AGTR2 (0.37) | IDH1AGTR2NPC1 | |
| SCHEMBL10183229 | 0.82 | IDH1 (0.38) | IDH1AGTR2 | |
| SCHEMBL10183927 | 0.82 | OPRM1 (0.36) | IDH1AGTR2 | |
| SCHEMBL10183315 | 0.80 | AGTR2 (0.35) | IDH1AGTR2PARP1 | |
| SCHEMBL10184031 | 0.79 | IDH1 (0.35) | IDH1AGTR2 | |
| SCHEMBL10185918 | 0.79 | IDH1 (0.31) | IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013107405-A1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2013-07-25 | — | — | WO | disclosed |
| WO-2012009678-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2012-01-19 | — | — | WO | disclosed |